Cargando…
Huntington’s disease iPSC models—using human patient cells to understand the pathology caused by expanded CAG repeats
A major advance in the study of Huntington’s disease (HD) has been the development of human disease models employing induced pluripotent stem cells (iPSCs) derived from patients with HD. Because iPSCs provide an unlimited source of cells and can be obtained from large numbers of HD patients, they ar...
Autores principales: | Kaye, Julia, Reisine, Terry, Finkbeiner, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264339/ https://www.ncbi.nlm.nih.gov/pubmed/35865413 http://dx.doi.org/10.12703/r/11-16 |
Ejemplares similares
-
Huntington’s disease mouse models: unraveling the pathology caused by CAG repeat expansion
por: Kaye, Julia, et al.
Publicado: (2021) -
FAN1 modifies Huntington’s disease progression by stabilizing the expanded HTT CAG repeat
por: Goold, Robert, et al.
Publicado: (2019) -
Extracellular vesicles improve GABAergic transmission in Huntington's disease iPSC-derived neurons
por: Beatriz, Margarida, et al.
Publicado: (2023) -
Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORT
por: Ha, Ainhi D., et al.
Publicado: (2012) -
Bioenergetic deficits in Huntington’s disease iPSC-derived neural cells and rescue with glycolytic metabolites
Publicado: (2020)